A new television segment is urging men to treat health screenings like a step-by-step manual, with a doctor mapping out exactly which tests matter at every age.
Story Snapshot
- Good Morning America aired a segment on November 11, 2026, titled “The new ‘manual’ for men and longevity.”
- Dr. Dhruv Khullar, a physician at Weill Cornell Medicine, explained which screenings matter most at different ages.
- Federal health guidelines show screening tests carry real trade-offs, including false positives and overdiagnosis.
- Prostate cancer screening remains one of the most debated tests because of its mixed benefits and harms.
A Doctor’s Breakdown of Age-Based Health Checks
Good Morning America published a segment explaining how men can track their health as they age. The program features Dr. Dhruv Khullar, a physician, associate professor at Weill Cornell Medicine, and contributing writer at The New Yorker. He walks viewers through the screenings doctors recommend at different life stages, aiming to simplify a topic that often confuses patients and families alike.
The segment fits into a growing media trend of packaging preventive health advice into simple checklists. Viewers get a doctor’s voice attached to the guidance, which adds credibility. But the broadcast itself does not spell out every recommended test, age cutoff, or source document behind the advice, leaving the full “manual” undefined beyond the short video format.
Why Health Screenings Are Never One-Size-Fits-All
Federal health researchers have long cautioned that screening tests are not automatically good for everyone. The U.S. Preventive Services Task Force, the government’s main body for reviewing screening evidence, says tests can lead to false alarms, unnecessary biopsies, and treatment for conditions that would never have caused harm. These risks apply across cancer screenings, not just for men’s health checks.
Prostate cancer testing shows this tension clearly. The task force found that screening can catch dangerous cancers early, but it also finds cancers that would never have become serious. Men who get treated for those slow-growing cases face real side effects, including incontinence and erectile dysfunction, without gaining any health benefit in return.
Balancing Early Detection With Real-World Risks
Evidence reviews back up this trade-off. One task force analysis concluded that prostate-specific antigen testing may lower the risk of dying from prostate cancer, but it comes bundled with false positives, biopsy complications, and overdiagnosis. Doctors are told to weigh these factors against a patient’s age, family history, and personal preferences rather than apply one blanket rule to every man.
Age itself changes the calculation. Research on screening in older patients stresses that life expectancy matters when deciding whether a test is worth it. A screening that makes sense for a 50-year-old may offer little benefit for a man in his 80s, since the cancer might never progress far enough to cause symptoms before other health issues take priority.
This is the backdrop against which segments like the Good Morning America feature operate. Millions of Americans rely on quick media explainers to understand complex medical choices, often because they lack time or access to sit down with a specialist. A short television segment can spark awareness, but the deeper screening decisions still depend on a one-on-one conversation between a patient and his doctor, not a universal script.
Sources:
youtube.com, goodmorningamerica.com, uspreventiveservicestaskforce.org, academic.oup.com
